Half of Gastric Cancer Patients Diagnosed From ER Visit

This article originally appeared here.
Share this content:
Half of Gastric Cancer Patients Diagnosed From ER Visit
Half of Gastric Cancer Patients Diagnosed From ER Visit

THURSDAY, Jan. 4, 2018 (HealthDay News) -- Half of patients with gastric cancer (GC) are diagnosed as a result of an emergency department visit, which is independently associated with increased mortality, according to a study published recently in the American Journal of Surgery.

Ian Solsky, M.D., from Montefiore Medical Center in Bronx, N.Y., and colleagues reviewed medical records to identify presenting location leading to diagnosis and treatment for 263 GC patients at a single institution (2009 to 2013). Patients with a diagnosis resulting from an emergency department visit (EDdx) were compared to those diagnosed at other locations (non-EDdx).

The researchers found that more than half of the GC patients were EDdx patients (52 percent). EDdx patients were older, had later cancer stages (stage IV: 50 percent, versus 24 percent in non-EDdx), had more comorbidities (≥3: 68 percent versus 47 percent), and presented with non-specific symptoms like bleeding (21 percent versus 5 percent). Race and insurance status did not differ between the groups. After adjustment for stage of diagnosis, EDdx was associated with increased mortality (adjusted hazard ratio, 1.9).

"Efforts should focus on reducing EDdx rates to improve GC outcomes," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »